ConCallIQ
Go Pro

TATA CONSUMER PRODUCTS FY25 Annual Earnings Summary

4 quarters covered · ₹17,604 Cr revenue · ₹925 Cr PAT · 11.0% average EBITDA margin.

Total annual revenue: ₹17,604 Cr
Annual PAT: ₹925 Cr
Average margin: 11.0%
Promise delivery: 0%

Quarter-by-quarter progression

QuarterRevenuePATMarginSentiment
Q1 FY25₹4,352 Cr₹289 Cr15.4%neutral
Q2 FY25₹4,200 Cr14.9%neutral
Q3 FY25₹4,444 Cr₹287 Crneutral
Q4 FY25₹4,608 Cr₹349 Cr13.6%neutral

Management promises made during the year

Capital Foods integration in 100 days

Current-quarter commentary contains related risk or weakness, so the promise appears not to have been delivered yet.

Q1 FY25
missed
Organic India integration in 100 days

Current-quarter commentary contains related risk or weakness, so the promise appears not to have been delivered yet.

Q1 FY25
missed
Rights issue to conclude by early Q2 FY25

Current-quarter commentary contains related risk or weakness, so the promise appears not to have been delivered yet.

Q1 FY25
missed
Organic India integration to complete in 100 days

Current-quarter commentary contains related risk or weakness, so the promise appears not to have been delivered yet.

Q2 FY25
missed
Capital Foods integration largely complete

Current-quarter commentary contains related risk or weakness, so the promise appears not to have been delivered yet.

Q2 FY25
missed
Rights issue to repay bridge debt

Current-quarter commentary contains related risk or weakness, so the promise appears not to have been delivered yet.

Q2 FY25
missed
NourishCo to return to 25-30% growth by end of Q3 FY25

Current-quarter commentary contains related risk or weakness, so the promise appears not to have been delivered yet.

Q3 FY25
missed
Further tea price increases expected

Current-quarter commentary contains related risk or weakness, so the promise appears not to have been delivered yet.

Q3 FY25
missed
Tea margin pressure to ease from Q4 FY25

Current-quarter commentary contains related risk or weakness, so the promise appears not to have been delivered yet.

Q4 FY25
missed
Capital Foods and Organic India acceleration in Q4

Current-quarter commentary contains related risk or weakness, so the promise appears not to have been delivered yet.

Q4 FY25
missed
Pharma channel expansion for Organic India

Current-quarter commentary contains related risk or weakness, so the promise appears not to have been delivered yet.

Q4 FY25
missed

Risks flagged during the year

Q1 FY25 · high

North Indian tea prices are up 15-20% and coffee prices (Robusta) up ~50% from two quarters ago, which could pressure margins if not passed through.

Q2 FY25 · high

Tea input costs are up ~30% YoY, but competitive intensity has limited price increases, pressuring India branded margins. Management indicated they will not sacrifice market share for profitability.

Q3 FY25 · high

Tea input costs remain elevated with only 40% passed through; if prices don't ease or further hikes aren't taken, margins could remain under pressure for two more quarters.

Q4 FY25 · high

Tea prices remain ~15% higher YoY; if crop normalizes slower than expected, margin recovery could be delayed beyond Q2 FY26.

Q1 FY25 · medium

NourishCo revenue grew only 7% due to intense summer impacting out-of-home consumption and delayed tactical pricing actions, raising concerns about the business's resilience.

Q1 FY25 · medium

Organic India deal closed on April 16, and inventory consolidation took longer than expected, potentially impacting near-term revenue and margins.

Q1 FY25 · medium

Quarterly amortization of INR 55 crore from acquisitions and higher interest costs from bridge financing are depressing reported PAT, with no near-term relief expected.

Q2 FY25 · medium

Record high coffee prices are causing demand stress in the non-branded solubles business, which could lead to lower profitability as inventory advantages fade.

Q2 FY25 · medium

Analyst raised concern about weak demand at Starbucks and across FMCG. Management acknowledged urban stress due to food inflation and delayed government spending, with same-store sales negative.

Q2 FY25 · medium

Tata Gluco+ lost competitiveness due to delayed price re-indexing versus peers and new entrants like Campa Cola, leading to a 30% premium to competitors. Corrective actions taken but recovery uncertain.

Q3 FY25 · medium

Coffee prices at 50-year highs; management is cautious on inventory and notes potential demand destruction if prices persist.

Q3 FY25 · medium

Analyst raised concern about new entrants and pricing aggression; management acknowledged matching deeper retail margins, impacting revenue growth.

What changed through the year

G

Q1 FY25 · Growth businesses to reach 30% of India portfolio

Management reiterated commitment to grow the growth businesses (including acquisitions) from 20% to 30% of the India portfolio, with these businesses growing at 30% CAGR.

G

Q1 FY25 · Organic India integration to complete in 100 days

Management committed to completing the integration of Organic India within 100 days from the April 16 closure, and is on track.

G

Q1 FY25 · Capital Foods integration largely complete

Integration of Capital Foods, including channel inventory cleanup, is complete and run rate is trending as expected.

G

Q1 FY25 · Rights issue to repay bridge debt

The rights issue, expected to close on August 19, will be used to repay short-term bridge financing of INR 3,000 crore raised for acquisitions.

G

Q2 FY25 · NourishCo to return to 25-30% growth by end of Q3 FY25

After re-indexing pricing on Tata Gluco+, management expects the ready-to-drink business to resume its normative growth trajectory by the end of the current quarter.

G

Q2 FY25 · Innovation to sales ratio to exceed 5% for full year FY25

The company is on track to deliver innovation as a percentage of sales above 5% for the full year, with Q2 at 4.1%.

G

Q2 FY25 · Further tea price increases expected

Staggered price increases have been actioned and more are planned to mitigate the 30% tea cost inflation, though full pass-through depends on competitive dynamics.

G

Q2 FY25 · Structural margin improvement over the long term

Management reiterated commitment to improving EBITDA margins year-on-year, supported by new acquisitions and operating leverage, though near-term tea cost volatility is a watch-out.

G

Q3 FY25 · Tea margin pressure to ease from Q4 FY25

Management expects Q3 to be the peak of tea margin pressure, with gradual improvement as price hikes flow through and new crop arrives in Q1 FY26.

G

Q3 FY25 · Capital Foods and Organic India acceleration in Q4

After stabilization, focus shifts to accelerating growth with innovation and expansion into food services and pharma channels, expecting a substantial jump in Q4.

G

Q3 FY25 · Growth businesses to contribute 30% of portfolio

Target for growth businesses (Sampann, Soulfull, etc.) to grow at 30% and contribute 30% of portfolio; currently at 27% contribution with 89% growth.

G

Q3 FY25 · Pharma channel expansion for Organic India

Piloted in 10 cities, pharma channel to expand to 40 cities next year, driving significant uplift for Organic India.

G

Q4 FY25 · EBITDA margin recovery to ~16% by Q2/Q3 FY26

Management expects EBITDA margins to normalize to ~16% as tea costs soften with a normal crop, with recovery starting by end of Q2 FY26.

G

Q4 FY25 · Growth businesses to grow at 30% CAGR

Sampann, Soulful, and other growth businesses are expected to continue growing at ~30% annually, maintaining their 30% revenue contribution target.

G

Q4 FY25 · Capital Foods and Organic India to grow at 30%

Management remains confident of 30% revenue growth for Capital Foods and Organic India in FY26, with margins in line with business case.

G

Q4 FY25 · Capex to remain at current year levels as % of revenue

Capex for FY26 will be similar to FY25 levels, with no significant new investments; Vietnam capex continues into H1 FY26.